Authors:
Caravaca, F
Arrobas, M
Pizarro, JL
Sanchez-Casado, E
Citation: F. Caravaca et al., Uraemic symptoms, nutritional status and renal function in pre-dialysis end-stage renal failure patients, NEPH DIAL T, 16(4), 2001, pp. 776-782
Citation: F. Caravaca et al., Serum albumin and other serum protein fractions in stable patients on peritoneal dialysis, PERIT DIA I, 20(6), 2000, pp. 703-707
Citation: F. Caravaca et al., Influence of residual renal function on dietary protein and caloric intakein patients on incremental peritoneal dialysis, PERIT DIA I, 19(4), 1999, pp. 350-356
Authors:
Caravaca, F
Arrobas, M
Pizarro, JL
Esparrago, JF
Citation: F. Caravaca et al., Metabolic acidosis in advanced renal failure: Differences between diabeticand nondiabetic patients, AM J KIDNEY, 33(5), 1999, pp. 892-898
Authors:
Caravaca, F
Pizarro, JL
Arrobas, M
Sanchez-Casado, E
Citation: F. Caravaca et al., Does angiotensin converting enzyme-inhibitor therapy influence the prevalence and severity of anemia in predialysis renal failure patients?, NEFROLOGIA, 19(6), 1999, pp. 538-544
Authors:
Robles, NR
Roncero, F
Arrobas, M
Vega, JLA
Casado, ES
Citation: Nr. Robles et al., Treatment with chlorambucil of renal amyloidosis secondary to rheumatoid arthritis. Study of 6 cases, MED CLIN, 113(12), 1999, pp. 456-458